Over the past 3 months, 4 analysts have published their opinion on ChemoCentryx (NASDAQ:CCXI) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
August 5, 6:59 AM
HC Wainwright & Co. analyst Edward White downgrades ChemoCentryx (NASDAQ:CCXI) from Buy to Neutral and lowers the price target from $101 to $52.
August 5, 4:00 AM
U.S. stocks closed mixed on Thursday following the release of weekly jobless claims data. Here is the list of some big stocks moving higher in the previous session.
August 4, 1:12 PM
Gainers InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares jumped 178.5% to $12.45 after gaining over 12% on Wednesday.
August 4, 12:18 PM
Shares of ChemoCentryx, Inc. (NASDAQ: CCXI) are skyrocketing Thursday following a groundbreaking announcement for the biopharmaceutical company. Why Is It Moving?
August 4, 10:44 AM
U.S. stocks traded lower this morning, with the Dow Jones falling more than 100 points on Thursday.
July 20, 5:37 PM
Gainers NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares increased by 15.1% to $0.63 during Wednesday's after-market session. The company's market cap stands at $16.7 million.
July 14, 1:50 PM
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.